Corcept Therapeutics (CORT) 5.33 $CORT Roche Gets FDA

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Corcept Therapeutics (CORT) 5.33 $CORT

Roche Gets FDA Nod for Emergency Use of Zika Virus Test
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:41AM CDT
Roche Holdings (RHHBY) announced that the FDA has issued an Emergency Use Authorization (EUA) for its LightMix Zika rRT-PCR Test.
ANIP: 59.74 (-1.12), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Novartis (NVS) Reports Positive Phase III Results on MS Drug
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:20AM CDT
Novartis AG (NVS) announced positive results from the phase III EXPAND study on its multiple sclerosis candidate BAF312.
TEVA: 50.39 (-0.17), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45), NVS: 78.77 (-0.57)

Mallinckrodt to Divest Nuclear Imaging Business for $690M
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:22AM CDT
Mallinckrodt plc (MNK) announced that it has entered into a definitive agreement to sell its Nuclear Imaging business to IBA Molecular for $690 million.
MNK: 74.54 (-0.51), MDCO: 39.17 (-0.97), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Cempra's Application for Pneumonia Drug Validated in EU
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 4:02PM CDT
Cempra, Inc. (CEMP) announced that the EMA has validated its MAA for the oral capsule and intravenous (IV) formulations of pipeline candidate solithromycin, for the treatment of community-acquired bacterial pneumonia.
AGN: 234.54 (-2.45), CEMP: 21.94 (+0.50), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:10AM CDT
Johnson & Johnson's (JNJ) seeks label expansion for Darzalex in combination with standard-of-care regimens for relapsed multiple myeloma patients.
JNJ: 119.34 (-0.13), AMGN: 170.06 (-0.70), CORT: 5.33 (-0.08)

Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:50AM CDT
Novartis AG (NVS) entered into a license agreement with privately held Cyon Therapeutics Inc. for its anti-PCSK9 antibody, LGT-209.
XNCR: 21.13 (-0.66), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45), NVS: 78.77 (-0.57)

Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:02AM CDT
Gilead Sciences (GILD) once-daily Truvada gains EU approval for reducing the risk of sexually acquired HIV-1 infection.
GILD: 78.38 (+0.46), GERN: 2.69 (unch), CORT: 5.33 (-0.08), ANIK: 47.24 (-0.21)

Roche Launches Accu-Chek Blood Glucose Monitoring System
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:47AM CDT
The launch of new systems will help Roche (RHHBY) offset the sales decline in the diabetes care business due to pricing pressure in the U.S. and reimbursement issues
ANIP: 59.74 (-1.12), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:52AM CDT
Supernus Pharmaceuticals, Inc. (SUPN) announced that the FDA has granted a tentative approval to the company's sNDA for a label expansion for Trokendi XR to include prophylaxis of migraine headache in adults.
ANIP: 59.74 (-1.12), SUPN: 21.38 (-0.49), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:43AM CDT
One such stock that you may want to consider dropping is Merus Labs International Inc. (MSLI), which has witnessed a significant price decline in the past four weeks
MSLI: 1.01 (+0.03), CORT: 5.33 (-0.08)

Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 4:32PM CDT
Insys Therapeutics, Inc. (INSY) announced that it has enrolled the first patient in a phase II trial on its pharmaceutical cannabidiol (CBD) product candidate.
INSY: 14.27 (-0.06), GWPH: 81.75 (-0.02), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Horizon (HZNP) Rayos Receives USPTO Notice of Allowance
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:22AM CDT
Horizon Pharma (HZNP) announced that it has received a notice of allowance from the U.S. Patent and Trademark Office with claims covering Rayos.
ANIP: 59.74 (-1.12), GERN: 2.69 (unch), HZNP: 18.80 (-0.21), CORT: 5.33 (-0.08)

Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:21AM CDT
Valeant Pharmaceuticals International, Inc. (VRX) announced that it has received the requisite lender approval for an amendment to its credit facility which is scheduled to close next week.
VRX: 29.03 (-1.22), TROW: 69.54 (-0.36), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:59AM CDT
GlaxoSmithKline (GSK) announced that its HIV-focused company, ViiV Healthcare has initiated a phase III program to support regulatory filings for a two-drug regimen of Tivicay and Epivir for the treatment for HIV-1 infection.
PFE: 34.80 (-0.08), GSK: 43.46 (+0.10), CORT: 5.33 (-0.08)

OncoGenex Down on Poor Phase III Data on Lead Cancer Drug
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:57AM CDT
Shares of OncoGenex Pharmaceuticals, Inc. (OGXI) were down 41% after the company announced disappointing data from its late-stage trial, AFFINITY, on custirsen in men with metastatic castrate-resistant prostate cancer.
OGXI: 0.54 (-0.03), ANIP: 59.74 (-1.12), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Endo (ENDP) Withdraws Label Expansion Filing for Opana ER
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 3:48PM CDT
Endo International (ENDP) announced that after discussions with the FDA the company has decided to withdraw its supplemental new drug application for Opana ER.
ENDP: 20.70 (-0.19), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Aurinia (AUPH) Stock Falls on Poor Phase II Lupus Study Data
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 10:08AM CDT
Shares of Aurinia Pharmaceuticals Inc. (AUPH) crashed 55% after the company reported mixed results from a phase IIb study, AURA-LV, on its pipeline candidate, voclosporin.
AUPH: 1.94 (-0.01), ANIP: 59.74 (-1.12), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Bristol-Myers to Reacquire Rights to Oncology Drug in Asia
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 8:26AM CDT
Bristol-Myers Squibb Company (BMY) will reacquire the rights to BMS777607 from Aslan Pharmaceuticals.
ANIP: 59.74 (-1.12), BMY: 57.39 (+0.15), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 11:24AM CDT
Mallinckrodt plc (MNK) announced that it will acquire privately held regenerative medicine company, Stratatech Corporation.
MNK: 74.54 (-0.51), MDCO: 39.17 (-0.97), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45)

Adverum (ADVM) Reports Narrower-than-Expected Q2 Loss
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 8:31AM CDT
Adverum (ADVM) reported a narrower-than-expected loss in the second quarter. The company also decided to discontinue the development of lead candidate.
ADVM: 3.58 (-0.16), CORT: 5.33 (-0.08), PCRX: 39.63 (-1.45), REGN: 392.55 (-2.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charlotte's Top-Tier Home Sales Surge: A $15M Milestone

Updated Category News Views 53

Charlotte's Luxury Market: A Rapid Ascent Folks, buckle up, because the luxury home market in Charlotte isn't just on the rise—it's practically sky-high. Back in 2016, the idea of splashing out over $5 million on a house was almost unheard of in this neck of the woods. Only one brave soul did it at the time. Fast forward to this past year, and things are looking starkly...

Continue Reading
Gayatri Pariwar Celebrates 100 Years with Massive Yoga Event

Updated Category News Views 52

An Impressive Centenary for Gayatri Pariwar Sometimes, you get hit by a wave so big you can't ignore it, and Gayatri Pariwar's centennial festival in New Delhi was one such tsunami. Picture this: countless souls gathered to mark a hundred years of spiritual and social reform, not just with chants and talks, but through an awe-inspiring mass yoga event. In my decades...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 39

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 569

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
191 Schools Honored for Academic Growth Success

Updated Category News Views 44

Celebrating Educational Progress Nationwide In a world where numbers fly off the stock tickers and translate into dollar signs in some corner office, it's refreshingly humbling to find real gains being celebrated in the educational sector. Curriculum Associates has tipped their hat to 191 schools that have done something remarkable: they've pushed students to stretch...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 84

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 146

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Univers Partners to Propel Physical AI Across Industries

Updated Category News Views 113

Univers Sets Sights on Global Physical AI Expansion Now here's a tune we've been humming for a while—AI is coming to take over the mundane, and Univers seems to think it's got the right band together to make that a full-blown concert in the built environment. Announced right in the heart of Antalya, Türkiye, at the esteemed COP31, we're seeing Univers grab hands with...

Continue Reading
Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 112

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Mastering Prescription Labels: Critical Insights for Safety

Updated Category News Views 0

Revolutionizing How We Approach Prescription Labels Prescription labels aren't just scraps of paper or stickers slapped on bottles; they're lifelines. The insight from pharmacy expert Sheldon Birch could turn a regular label into a powerful tool for health management. According to Birch, the label is often disregarded yet speaks volumes about the medication you've got in...

Continue Reading

Top 5 Most Recently Viewed Articles

Ray Dalio Warns of Economic Heart Attack and Gold Investment

Updated Category News Views 330

Debt-Fueled Risks in the U.S. Economy Ray Dalio, founder of Bridgewater Associates, has recently shared his concerns regarding the growing debt burden facing the U.S. economy. According to Dalio, this financial strain resembles arterial blockage, leading to the possibility of a severe economic "heart attack." His warning speaks volumes as the national debt continues to...

Continue Reading
Citi Projects Stronger Global Economic Growth in 2024

Updated Category News Views 249

Global Economic Outlook for 2024 In a recent report, Citi's group of economists has expressed optimism about the global economic scene for 2024. They predict that the economy will exceed earlier expectations, thanks in part to lower interest rates and positive trends emerging from several markets. These elements create a more encouraging environment for growth compared to...

Continue Reading
Quarterhill Welcomes David Charron as CFO to Drive Growth

Updated Category News Views 226

David Charron Takes the Helm as Quarterhill's CFO Quarterhill Inc. (TSX: QTRH) is excited to announce that David Charron has been appointed as the new Chief Financial Officer (CFO). This strategic move comes as the company gears up for its next phase of growth. David brings over 15 years of experience in leadership roles within public technology companies, making him a...

Continue Reading
Autolus Therapeutics: Key Insights Ahead of Earnings Release

Updated Category News Views 209

Overview of Autolus Therapeutics Earnings Report Autolus Therapeutics (NASDAQ: AUTL) is preparing to share its quarterly earnings results soon. Investors are keenly anticipating this announcement, which will give them a clearer picture of the company’s performance and future direction. Forecasts and Market Expectations Analysts are projecting a loss per share (EPS) of...

Continue Reading
Blue Diamond Growers Earns Star Site Award for Safety Excellence

Updated Category News Views 299

Blue Diamond Growers Achieves Recognition for Safety Standards Blue Diamond Growers, the leading cooperative in almond marketing and processing, has reached a significant milestone by receiving the "Star Site" designation from Cal/OSHA. This recognition is awarded to employers who have excelled in managing safety and health programs effectively. Exceptional Safety at the...

Continue Reading